NKGen Biotech, Inc. Annual Return On Equity in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
NKGen Biotech, Inc. quarterly/annual Return On Equity history and growth rate from 2021 to 2023.
  • NKGen Biotech, Inc. Return On Equity for the quarter ending June 30, 2024 was 158 %, a 36.5% decline year-over-year.
  • NKGen Biotech, Inc. annual Return On Equity for 2023 was 283 %, a 207% increase from 2022.
  • NKGen Biotech, Inc. annual Return On Equity for 2022 was 92.2 %, a 1339% increase from 2021.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 283 +191 +207% Jan 1, 2023 Dec 31, 2023
2022 92.2 +85.8 +1339% Jan 1, 2022 Dec 31, 2022
2021 6.4 Jan 28, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.